Latest AI and machine learning research in lymphoma for healthcare professionals.
INTRODUCTION: Lung cancer remains the leading cause of cancer mortality worldwide despite advances in treatment. Patient-related factors beyond tumour characteristics may influence prognosis but are seldom integrated into staging or risk stratification. METHODS: We analysed data from 59 101 patients with resectable non-small cell lung cancer (NSCLC) in the French nationwide Epithor database. Using...
BACKGROUND: Mantle cell lymphoma (MCL) is a rare, biologically heterogeneous B-cell malignancy with highly variable outcomes. Existing prognostic tools are suboptimal. We developed an interpretable deep learning framework integrating baseline [18F]FDG PET/CT and electronic health record (EHR) data for individualized risk stratification. METHODS: In this multicenter study, 187 treatment-naïve MCL p...
BACKGROUND: Multiparametric MRI (mpMRI) and ^68Â Ga-PSMA PET/CT are widely used for prostate cancer (PCa) diagnosis but remain limited by false positiv...
Pre-operative identification of cervical lymph-node metastasis (LNM) guides surgical extent in papillary thyroid carcinoma (PTC) but remains imperfect...
Diffuse large B-cell lymphoma (DLBCL) features an immunosuppressive tumor microenvironment (TME), yet the molecular drivers connecting metabolic repro...
Cell type-specific gene expression from single-cell RNA sequencing (RNA-seq) is valuable for breast cancer precision oncology but available cohorts ar...
Childhood obesity is a growing global health crisis associated with an increased risk of metabolic and cardiovascular diseases in adulthood. While acc...
Cell therapies have demonstrated great potential for treating a broad range of diseases where conventional treatments have failed. However, long devel...
Liver fibrosis staging (LFS) informs treatment decisions and prognostic assessment in liver disease. Multiparametric MRI enables non-invasive, quantit...
BACKGROUND: Accurate tumor node metastasis (TNM) staging is fundamental for treatment planning and prognosis in non-small cell lung cancer (NSCLC). Ho...
BACKGROUND: Lack of readily available recurrence data has limited the use of electronic health records (EHR) for risk assessment of cancer recurrence ...
BACKGROUND: Overdose rates in the U.S. rose dramatically during the COVID-19 pandemic. Well-documented racial and sociodemographic inequities in the i...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common types of cancer globally. However, HCC features poor prognosis due to complex pat...
We present a large whole-body and total-body curated dataset of dual-modality 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-Positron Emission Tomography/Compu...
PURPOSE: To characterize clinicopathologic and imaging differences between ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML) and IgG4-r...
Precise assessment of cell growth, count, and viability is a prerequisite for biological and medical research. Traditional cell analytics involve manu...
Delayed diagnosis of Parkinson's disease (PD) due to undetectable early pathological changes remains a major clinical challenge limiting effective tre...
PURPOSE: Preoperative identification of lymph node metastasis (LNM) in cervical cancer is crucial for guiding therapeutic strategies but remains clini...
Precise staging of endometriosis remains a clinical challenge, as current diagnosis depends almost entirely on laparoscopic visualization-an invasive ...